451 related articles for article (PubMed ID: 19174106)
21. Is there a benefit to extending the duration of Helicobacter pylori sequential therapy to 14 days?
Hsu PI; Wu DC; Wu JY; Graham DY
Helicobacter; 2011 Apr; 16(2):146-52. PubMed ID: 21435093
[TBL] [Abstract][Full Text] [Related]
22. Variables influencing outcome of Helicobacter pylori eradication therapy in South China.
Cai W; Zhou L; Ren W; Deng L; Yu M
Helicobacter; 2009 Oct; 14(5):91-6. PubMed ID: 19751433
[TBL] [Abstract][Full Text] [Related]
23. Meta-analysis: is sequential therapy superior to standard triple therapy for Helicobacter pylori infection in Asian adults?
Yoon H; Lee DH; Kim N; Park YS; Shin CM; Kang KK; Oh DH; Jang DK; Chung JW
J Gastroenterol Hepatol; 2013 Dec; 28(12):1801-9. PubMed ID: 24118110
[TBL] [Abstract][Full Text] [Related]
24. A comparison between 15-day sequential, 10-day sequential and proton pump inhibitor-based triple therapy for Helicobacter pylori infection in Korea.
Lee JW; Kim N; Kim JM; Nam RH; Kim JY; Lee JY; Lee DH; Jung HC
Scand J Gastroenterol; 2014 Aug; 49(8):917-24. PubMed ID: 24988873
[TBL] [Abstract][Full Text] [Related]
25. Duration of the metronidazole-containing regimen for eradication of Helicobacter pylori infection in northern Japan.
Fukuda S; Shimoyama T; Tanaka M; Nakasato F; Fukushi M; Munakata A
Jpn J Infect Dis; 2006 Dec; 59(6):367-9. PubMed ID: 17186954
[TBL] [Abstract][Full Text] [Related]
26. The influence of pretreatment with PPI on Helicobacter pylori eradication: A systematic review and meta-analysis.
Kuang S; Xu J; Chen M; Zhang Y; Shi F; Lu X
Medicine (Baltimore); 2021 Nov; 100(47):e27944. PubMed ID: 34964772
[TBL] [Abstract][Full Text] [Related]
27. The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication.
Kim MN; Kim N; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Kim JS; Jung HC; Song IS
Helicobacter; 2008 Aug; 13(4):261-8. PubMed ID: 18665934
[TBL] [Abstract][Full Text] [Related]
28. A randomized clinical trial to determine the efficacy of regimens containing clarithromycin, metronidazole, and amoxicillin among histologic subgroups for Helicobacter pylori eradication in a developing country.
Fischbach LA; Bravo LE; Zarama GR; Bravo JC; Ojha RP; Priest EL; Collazos T; Casabon AL; Guerrero LZ; Singh KP; Correa P
Helicobacter; 2009 Apr; 14(2):100-8. PubMed ID: 19298337
[TBL] [Abstract][Full Text] [Related]
29. Effect of dosing schemes of amoxicillin on eradication rates of Helicobacter pylori with amoxicillin-based triple therapy.
Furuta T; Sugimoto M; Yamade M; Uotani T; Sahara S; Ichikawa H; Yamada T; Osawa S; Sugimoto K; Watanabe H; Umemura K
J Clin Pharmacol; 2014 Mar; 54(3):258-66. PubMed ID: 24122836
[TBL] [Abstract][Full Text] [Related]
30. Effect of the mucolytic erdosteine on the success rate of PPI-based first-line triple therapy for Helicobacter pylori eradication: a prospective, double-blind, randomized, placebo-controlled study.
Abut E; Yaşar B; Güveli H; Bölükbaş C; Bölükbaş FF; Dalay AR; Kurdaş OO
Scand J Gastroenterol; 2010 Jun; 45(6):677-83. PubMed ID: 20334478
[TBL] [Abstract][Full Text] [Related]
31. Standard triple therapy versus sequential therapy for eradication of Helicobacter pylori in treatment naïve and retreat patients.
Abuhammour A; Dajani A; Nounou M; Zakaria M
Arab J Gastroenterol; 2016 Sep; 17(3):131-136. PubMed ID: 27665525
[TBL] [Abstract][Full Text] [Related]
32. Assessment of Sequential and Standard Triple Therapy in Treatment of Helicobacter pylori Infection in Children Dependent on Bacteria Sensitivity to Antibiotics.
Iwańczak BM; Borys-Iwanicka A; Biernat M; Gościniak G
Adv Clin Exp Med; 2016; 25(4):701-8. PubMed ID: 27629844
[TBL] [Abstract][Full Text] [Related]
33. Randomized clinical trial comparing 10-day sequential, 7-day concomitant and 7-day standard triple therapies for Helicobacter pylori eradication.
Tepeš B; Vujasinović M; Šeruga M; Stefanovič M; Forte A; Jeverica S
Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):676-83. PubMed ID: 26862930
[TBL] [Abstract][Full Text] [Related]
34. Gatifloxacin-based triple therapy as a third-line regimen for Helicobacter pylori eradication.
Nishizawa T; Suzuki H; Nakagawa I; Iwasaki E; Masaoka T; Hibi T
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S167-70. PubMed ID: 19120892
[TBL] [Abstract][Full Text] [Related]
35. [Failure of Helicobacter pylori eradication--suggestions for further therapy].
Prónai L; Tulassay Z
Orv Hetil; 2003 Jun; 144(26):1299-302. PubMed ID: 12894674
[TBL] [Abstract][Full Text] [Related]
36. Systematic review and meta-analysis: triple therapy combining a proton-pump inhibitor, amoxicillin and metronidazole for Helicobacter pylori first-line treatment.
Puig I; Baylina M; Sánchez-Delgado J; López-Gongora S; Suarez D; García-Iglesias P; Muñoz N; Gisbert JP; Dacoll C; Cohen H; Calvet X
J Antimicrob Chemother; 2016 Oct; 71(10):2740-53. PubMed ID: 27342548
[TBL] [Abstract][Full Text] [Related]
37. Treatment of Helicobacter pylori infection.
Egan BJ; Marzio L; O'Connor H; O'Morain C
Helicobacter; 2008 Oct; 13 Suppl 1():35-40. PubMed ID: 18783520
[TBL] [Abstract][Full Text] [Related]
38. Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea.
Kim N; Park SH; Seo GS; Lee SW; Kim JW; Lee KJ; Shin WC; Kim TN; Park MI; Park JJ; Hong SJ; Shim KN; Kim SW; Shin YW; Chang YW; Chun HJ; Lee OJ; Jeon WJ; Park CG; Cho CM; Park CH; Won SY; Lee GH; Park KS; Shin JE; Kim HU; Park JY; Chae HS; Song GA; Kim JG; Yoon BC; Seol S; Jung HC; Chung IS
Helicobacter; 2008 Dec; 13(6):542-9. PubMed ID: 19166420
[TBL] [Abstract][Full Text] [Related]
39. Helicobacter pylori eradication: role of individual therapy constituents and therapy duration.
Qasim A; O'Morain CA; O'Connor HJ
Fundam Clin Pharmacol; 2009 Feb; 23(1):43-52. PubMed ID: 19207543
[TBL] [Abstract][Full Text] [Related]
40. The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults.
Fallone CA; Chiba N; van Zanten SV; Fischbach L; Gisbert JP; Hunt RH; Jones NL; Render C; Leontiadis GI; Moayyedi P; Marshall JK
Gastroenterology; 2016 Jul; 151(1):51-69.e14. PubMed ID: 27102658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
